Dosing (Picture1)
Salicor Patch
Product Images NDC 83881-501
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Salicor (NDC 83881-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Clinic Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Carton Back (Salicor Carton Back 092525)
This text provides detailed information about a product containing Triethanolamine Salicylate, an NSAID, used for temporary pain relief. It includes instructions on proper use, warnings, and precautions such as not using the product on certain areas like the face or genitals. It advises on when to consult a doctor before use, and to be cautious of potential side effects like increased risk of heart attack or stroke. Additionally, it offers guidance on disposal and storage of the product, as well as directions for adults on how to apply and replace the patches for pain relief. The product also comes with a helpline for any questions or comments.*
Carton Front (Salicor Carton Front 092525)
This is a product label for Salicoer, containing Triethanolamine Salicylate at 10%. It is designed for active wear, offering fast-acting relief with all-night hold and water resistance. The packaging includes 15 systems of size 6cmx95cm (24inx3.75in), and it is dispensed by prescription.*
Ppi Back (Salicor Package Insert Back 092525)
Salicor™ is an external analgesic product designed for temporary relief of minor pain associated with arthritis, backaches, muscle strains, sprains, and bruises. It contains 10% triethanolamine salicylate as the active ingredient. This product inhibits cyclooxygenase (COX) enzymes to reduce inflammation and pain locally. It has low systemic absorption, reducing the risk of systemic side effects. Triethanolamine salicylate is distributed within cells and tissues, with predictable levels at the application site. Metabolism primarily occurs in the liver, with the product being excreted through urine. Salicor™ has not been studied for effects on fertility. It is provided in 1 carton with 15 systems and should be stored at room temperature, away from children, excessive heat, and sunlight. For more information, contact Clinic Pharma.*
Ppi Front (Salicor Package Insert Front 092525)
Salicor is a prescription topical analgesic indicated for temporary relief of minor muscle and joint aches, strains, sprains, and bruises. It contains Triethanolamine Salicylate at 10%. The application instructions involve cleaning the affected area, applying Salicor for 8-12 hours, and may be cut into smaller sizes if needed. However, it is contraindicated in patients with hypersensitivity to salicylates, asthma, and in pregnancy past 20 weeks. Precautions include avoiding tight bandaging, heat sources, and contact with eyes. Adverse reactions may include localized irritation or allergic reactions. It's essential to seek medical attention for serious symptoms like severe headaches, heart symptoms, or nervous system reactions. Patients should not use Salicor with other external analgesics and exercise caution in combination with certain antiarrhythmic drugs.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
